Drug Development
Drug Development

Filter

Locations


Result types


Type of company


Industries


Company status

Number of employees

to

Founding year

to


Lock keywords

Exclude keywords

Optional keywords

Clear filters

Products and services for "Drug Development"

Image for Drug Development Strategy Experts 
Product

Verified

Drug Development Strategy Experts 

Premier Consulting: Need help with Drug Development Strategy? Contact our team of experts today!

by Premier Consulting

Image for Model-Based Drug Development :: Parexel
Product

Verified

Model-Based Drug Development :: Parexel

Model-Based Drug Development | Biomarkers | Bioanalytics | Biostatistics | PK/PD | Browse our latest insights

by ExecuPharm

Image for Orphan Drug Development - Voisin Consulting Life Sciences
Product

Verified

Orphan Drug Development - Voisin Consulting Life Sciences

Orphan drugs are indicated for rare diseases with low prevalence. Most health authorities promote the development of orphan drugs by offering incentives to companies developing this treatments

by Voisin Consulting Life Sciences (VCLS)

Image for Drug Development & Design | R&D Areas - iBET
Product

Verified

Drug Development & Design | R&D Areas - iBET

iBET's drug discovery and drug development includes biochemical and biophysical characterization of therapeutic molecules and target molecules.

by iBET - Instituto de Biologia Experimental e Tecnológica

Image for No Doubts with your drug development
Product

Verified

No Doubts with your drug development

Cross checking your HPLC method for impurity profiling with TLC...

by European Pharmaceutical Review

Image for Drug Development and Repurposing with metaphactory and GraphDB use case
Product

Verified

Drug Development and Repurposing with metaphactory and GraphDB use case

Knowledge Graph Driven, F.A.I.R. Data Applications for Life Sciences and Pharma, Powered by metaphactory & GraphDB

by Ontotext

Image for Drug Development – Symeres
Service

Verified

Drug Development – Symeres

Drug Development | An experienced team to take your route to the next level. | Process Research and Development | GMP Manufacturing | GMP Starting Materials | Solid State Chemistry and Pre-Formulation Research | ICH Stability Studies | Quality Unit | EHS Compliance | Feel free to contact us! | Files

by MercachemSyncom

Image for Anticancer Drug Development– Booksmart
Product

Verified

Anticancer Drug Development– Booksmart

Anticancer Drug Development

by Booksmart

Image for Drug Development Safety and Pharmacovigilance | Linguamatics
Product

Verified

Drug Development Safety and Pharmacovigilance | Linguamatics

Drug Development Safety and Pharmacovigilance | Share this page | Background | Drug Development Pipeline | Drug Discovery | Preclinical Trials | Phase 1 Clinical Trials | Phase 2 Clinical Trials | Phase 3 Clinical Trials | New Drug Application (NDA) | Regulatory (GLP) Toxicology | Post-market Surveillance (Pharmacovigilance) | Shortcomings of the Drug Development Process | Drug Development Costs | Time to Market | Effectiveness | Data Sources on Drug Development Safety | Transforming Unstructured Text | Query Flexibility | Domain Ontologies | A Choice of Formats | Summary | Answering Key Questions on Drug Safety | Direct Questions | Indirect Questions | Drug Similarity Questions | Assessing Safety during Preclinical Trials | Early Identification of Potential Safety/Toxicity Issues | Preclinical Safety and Toxicity | Financial Advantages of Early Detection | Legacy Safety Reports - Case Study | Chronic Toxicology Studies - Case Study | Searching Clinical Investigator Brochures for Safety Assessments | Implementing an Adverse Event Reporting System (AERS) | Comparing Real World Evidence and FDA Data - Case Study | Data Mining at the FDA | Pharmacovigilance and Post-market Surveillance | Systematic literature searching for pharmacovigilance signals | Leveraging NLP for Adverse Event Reporting | Pharmacovigilance, clinical safety and regulatory | Structuring Adverse Event Reports | The Application of Text Mining and Real World Evidence at Pharmaceutical Company Pfizer | Case Studies | Legacy Safety Reports | Chronic Toxicology Studies  | Comparing Real World Evidence and FDA Data | Implementing an Adverse Event Reporting System (AERS) | Downloads | Linguamatics NLP - Advancing Drug Safety with Natural Language Processing - Fact Sheet.pdf pdf 376.53 KB | Related Blogs | Drug Safety Landscapes – Painting the Picture with Natural Language Processing | Autocoding adverse events to MedDRA – time to throw out the manual | From molecule to market: Today’s NLP optimizes every step of drug development | Related Resources | Webinar: Introduction to Natural Language Processing from Molecule to Market | Webinar: Innovating drug safety with natural language processing | Fact Sheet: IQVIA Safety Intelligence Hub | Fact Sheet: IQVIA NLP Risk Adjustment Solution | Ready to get started?

by Linguamatics

Image for AGT's Rapid Drug Development Process: The Power of the Lentiviral Vector - American Gene Technologies
Product

Verified

AGT's Rapid Drug Development Process: The Power of the Lentiviral Vector - American Gene Technologies

AGT's rapid drug development process revolves around our thousands of tested and banked lentiviral vectors which can be adapted to treat new target diseases.

by American Gene Technologies International

1110 companies for "Drug Development"

Beacon Targeted Therapies's Logo

London, United Kingdom

51-100 Employees

2015

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals, tracking targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development. Beacon‭ ‬is part of‭ ‬Hanson Wade‭ ‬and was invented in 2015‭. ‬Hanson Wade gives people the clarity to see where opportunity lies‭. ‬We work in highly specialized fields to provide unmatched depth and quality of content‭. ‬We work in sectors where the quality of information is the difference between success and failure‭. ‬. Hanson Wade organizes a large portfolio of highly respected meetings in targeted therapies including World ADC‭, ‬CAR-TCR Summit‭, ‬Gene Therapy and World Bispecific to name but a few‭.‬.

+

Featured

Product
Image for Make faster, better drug development decisions

Make faster, better drug development decisions

... Beacon - Gene Therapy Database - Make faster and better informed drug development ...

Elim Pediatric Pharmaceuticals Inc.'s Logo

+

Featured

Core business
Image for Top-Quality Drug Development and Services

Top-Quality Drug Development and Services

... Top-Quality Drug Development and ...

Leads to Development's Logo

Paris, France

2009

Leads to Development (L2D) provides your company with a team of experienced developers delivering the rapid expert support your innovative product requires. We are using an efficient project management process to ensure delivery of high-quality development programmes. Each L2D project manager has transversal expertise throughout the different aspects and phases of product development. This results in rapid progression of your product towards your next milestones. Our international, multidisciplinary team of expert drug developers will work with you as an extension of your own team.

+

Featured

Core business
Image for Accelerating your new drug development

Accelerating your new drug development

... NONCLINICAL CMC DRUG DEVELOPMENT SERVICES. Accelerating your new drug development. Ready-to-go committed team for rapid delivery. 150+ programmes delivered. ...

BIOSTRAT Biotech Consulting's Logo

Denmark

1-10 Employees

2007

Do you want to know which discount rates and valuation methods (ex. rNPV, eNPV, NPV, benchmarking) your industry peers are using when making financial valuations of biotech/pharma projects? Participate in a brief anonymous survey (10-15 mins.) on valuation methods and discount rates in pharma and biotech – and get the whitepaper with the results. Nicolaj Højer Nielsen is a serial entrepreneur, business angel and founder of Biostrat Biotech Consulting Aps. Nicolaj has for the last twenty years been building (and investing in) startups within biotechnology, medtech and IT. He lectures on Entrepreneurship at Copenhagen Business School and is the author of the Startup Funding book.

+

Featured

Core business
Image for Valuation methods and discount rates in drug development

Valuation methods and discount rates in drug development

... Study on biotech valuation methods and discount rates in drug development.. NPV vs. rNPV method. ...

Intelligencia's Logo

New York, United States

51-100 Employees

2017

+

Featured

Product
Image for intelligencia.ai - Accelerating Innovation in Drug Development.

intelligencia.ai - Accelerating Innovation in Drug Development.

... Our solutions enable you to minimize risks in drug development, streamline productivity and lower cost across key aspects of pre-clinical and clinical development, Portfolio Strategy, and Business Development. ...

Fidelity Regulation Therapeutics's Logo

Taoyuan City, Taiwan

1-10 Employees

2019

Fidelity Regulation Therapeutics Inc., FRT, is a start-up clinical stage drug development company. Founded in 2019, FRT consists of a professional team with consultant team from both research institutes and the industries, including small/large molecules drugs design, cell therapy and clinical trials professionals. Shiau is the founder, President and Chief Executive Officer of FRT. Prior to FRT, He served as an associate professor in National Defense Medical Center (NDMC). He devoted most of his life in research, 38 years and still counting.

+

Featured

Core business
Image for Inheriting Scientific Innovation for Drug Development

Inheriting Scientific Innovation for Drug Development

... Inheriting Scientific Innovation for Drug Development ...

QR Genetics's Logo

Tel Aviv-Yafo, Israel

1-10 Employees

2019

From personalized medicine for individuals to precision medicine for populations QRGenetics develop a powerful AI-supported drug discovery engine that efficiently produces drug targets for genetic disease therapies, by deploying a rapid validation process on individuals with spatially similar rare disease mutations. From personalized medicine for individuals to precision medicine for populations QRGenetics develop a powerful AI-supported drug discovery engine that efficiently produces drug targets for genetic disease therapies, by deploying a rapid validation process on individuals with spatially similar rare disease mutations.

+

Featured

Core business
Image for A drug development engine for genetic diseases A drug development engine for genetic diseases

A drug development engine for genetic diseases A drug development engine for genetic diseases

... A drug development engine for genetic ...

Haisco-USA Pharmaceuticals Inc.'s Logo

San Diego, United States

1-10 Employees

2020

Haisco-USA Pharmaceuticals, Inc is a specialty pharmaceutical company focused on the development of innovative drugs for anesthesia and pain management to improve the lives of patients. Copyright © 2020 Haisco-USA Pharmaceuticals, Inc. - All Rights Reserved.

+

Featured

Core business
Image for Haisco-USA: Innovative Drug Development for Anesthesia and Pain Management

Haisco-USA: Innovative Drug Development for Anesthesia and Pain Management

... Haisco-USA Pharmaceuticals, Inc. focuses on drug development for anesthesia and pain ...

Venn Life Sciences's Logo

Dalkey, Ireland

51-100 Employees

2008

Venn Life Sciences offers drug development consultancy and services to help bring products to the market quickly and efficiently. A trusted partner in the life science industry for over 25 years. Get in touch and see how we can help you with your clinical trial management and resourcing options. This enables us to create, plan and execute drug development programmes effectively for our global customers, ranging from virtual start-up companies to established pharma companies. Venn’s capabilities and expertise includes CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study design and Methodology, Data Management,... In drug development, a proper clinical development strategy, implemented at an early stage of product development, helps to guide the success (and cost-effectiveness) of the product development.

+

Featured

Service
Image for Drug Development Consultancy

Drug Development Consultancy

... Venn Life Sciences are a drug development and clinical trial services company based in the UK, Paris and Breda. Learn more about all our drug development services. ...

Acoustic Bio's Logo

Mountain View, United States

1-10 Employees

Acoustic Bio is pioneering technologies that automate and scale patient-derived organoids (PDOs) screening for personalized drug development. Our innovative platform integrates microfluidics, live imaging, acoustic technology, and machine learning to deliver a first-in-class high-throughput Organoid-on-a-Chip screening platform. It is designed for small and large biotech and pharma, providing a cost-effective solution to generate large-scale data to better identify new drugs that will work in patients. Real-time video of acoustic retrieval of brain organoid. We are a group of technologists working at the intersections of engineering and biology to build a novel platform to accelerate single-cell analysis.

+

Featured

Core business
Image for Organoid-on-a-Chip Platform to Accelerate Personalized Drug Development

Organoid-on-a-Chip Platform to Accelerate Personalized Drug Development

... Organoid-on-a-Chip Platform to Accelerate Personalized Drug Development ...

Show More

„Drug Development“

Drug development is the process of bringing a new pharmaceutical product from discovery and preclinical research to market. This process involves a variety of activities including drug discovery and design, preclinical testing, clinical trials, regulatory review, and commercialization. Along the way, potential drug candidates are identified and developed, tested for efficacy and safety, and approved for marketing. The ultimate goal is to create safe and effective medicines that improve patients' lives.